SQUINTO STEPHEN P 4
4 · Chemomab Therapeutics Ltd. · Filed Apr 21, 2021
Insider Transaction Report
Form 4
SQUINTO STEPHEN P
Director
Transactions
- Award
Option to Purchase American Depositary Shares
2021-04-19+23,768→ 23,768 totalExercise: $27.26Exp: 2031-04-19→ American Depositary Shares (23,768 underlying)
Holdings
- 47,938
American Depositary Shares
- 32,928
Option to Purchase American Depositary Shares
Exercise: $1.49Exp: 2028-10-21→ American Depositary Shares (32,928 underlying) - 424
Option to Purchase American Depositary Shares
Exercise: $0.67Exp: 2025-11-18→ American Depositary Shares (424 underlying) - 21,095
Option to Purchase American Depositary Shares
Exercise: $1.49Exp: 2027-11-19→ American Depositary Shares (21,095 underlying) - 2,109
Option to Purchase American Depositary Shares
Exercise: $0.80Exp: 2026-09-13→ American Depositary Shares (2,109 underlying) - 40,362
Option to Purchase American Depositary Shares
Exercise: $1.48Exp: 2030-11-19→ American Depositary Shares (40,362 underlying)
Footnotes (6)
- [F1]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F2]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F3]These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
- [F4]These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
- [F5]14,059 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 7,036 of these options will vest and become exercisable in three installments, with 1/3 of the options vesting on each three month anniversary commencing on May 16, 2021, subject to the Reporting Person's continued service.
- [F6]5,042 of these options to purchase ADSs have vested and are exercisable as of the date hereof, while the remaining 35,320 of these options will vest and become exercisable in seven installments, with 1/7 of the options vesting on each three month anniversary commencing on May 19, 2021, subject to the Reporting Person's continued service.